Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)
Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –
Medpace price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Medpace's price to book ratio was 42.8× on Nov 11, 2026, against 56.8× a year earlier. Over the last 5 years it ranged from 5.0× to 95.3×, with a median of 18.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 42.8× | −11.1 |
| 2025 | Dec 31, 2025 | 53.9× | +42.2 |
| 2024 | Dec 31, 2024 | 11.7× | −8.3 |
| 2023 | Dec 29, 2023 | 20.0× | +1.1 |
| 2022 | Dec 30, 2022 | 18.9× | +10.2 |
| 2021 | Dec 31, 2021 | 8.7× | +2.4 |
| 2020 | Dec 31, 2020 | 6.3× | +1.9 |
| 2019 | Dec 31, 2019 | 4.4× | +1.0 |
| 2018 | Dec 31, 2018 | 3.3× | +0.9 |
| 2017 | Dec 29, 2017 | 2.5× | +0.1 |
| 2016 | Dec 30, 2016 | 2.4× | – |
See a number that looks wrong?